An Up-to-Date Review on Cerebral Microbleeds

被引:33
作者
Wu, Yan [1 ]
Chen, Tao [1 ]
机构
[1] Kunming Med Sch, Affiliated Hosp 1, Dept Neurol, Xichang Rd 295, Kunming, Yunnan Province, Peoples R China
关键词
Cerebral microbleeds (CMBs); cerebral small-vessel disease (CSVD); risk factor; cognition impairment; SMALL-VESSEL DISEASE; TRANSIENT ISCHEMIC ATTACK; RISK-FACTORS; ALZHEIMER-DISEASE; STROKE; COL4A1; ACCUMULATION; HYPERTENSION; PREVALENCE; PREVENTION;
D O I
10.1016/j.jstrokecerebrovasdis.2016.03.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral microbleeds (CMBs) are small cerebrovascular lesions. More and more CMBs have been found in patients with ischemic stroke, dementia, and cerebral amyloid angiopathy, as well as some normal elderly populations. The objective of this study is to summarize the main risk factor, impairment, and therapy of CMBs. Methods: We searched and scanned all the literature with the keyword "cerebral microbleeds" or "CMBs" in the database of PubMed and Elsevier. Results: The risks factors for CMBs are complicated, including those that cause large-vessel disease, such as hypertension and old age, and those that cause small-vessel disease, such as amyloid deposits, endothelial lesions, and atrial fibrillation. Moreover, drugs and therapies used to treat cerebrovascular diseases such as statin, intravenous thrombolysis, and coumarin may also increase risk of CMBs. The relationship between antiplatelet treatment and CMBs is now unclear. Gene polymorphisms have been considered to be associated with CMBs. Gene mutations involving collagen type IV alpha 1 and collagen type IV alpha 2, sortilin-related receptor gene, forkhead box C1, and paired-like homeodomain 2 were reported to affect CMBs with the modification of corresponding proteins and functions. The cognition impairment caused by CMBs draws great attention. White matter deterioration is the possible answer. However, different studies could not reach the same conclusion on the damage of cognition of CMBs. Conclusions: Further research is needed to provide effectual therapeutic proposals for CMBs, which differ from the treatment for large-artery disease and dementia. (C) 2016 Published by Elsevier Inc.
引用
收藏
页码:1301 / 1306
页数:6
相关论文
共 46 条
[1]  
Adam B, 2013, ALZHEIMERS DEMENT, V9, P129
[2]   Use of Coumarin Anticoagulants and Cerebral Microbleeds in the General Population [J].
Akoudad, Saloua ;
Darweesh, Sirwan K. L. ;
Leening, Maarten J. G. ;
Koudstaal, Peter J. ;
Hofman, Albert ;
van der Lugt, Aad ;
Stricker, Bruno H. ;
Ikram, M. Arfan ;
Vernooij, Meike W. .
STROKE, 2014, 45 (11) :3436-3439
[3]   Cerebral microbleeds are related to loss of white matter structural integrity [J].
Akoudad, Saloua ;
de Groot, Marius ;
Koudstaal, Peter J. ;
van der Lugt, Aad ;
Niessen, Wiro J. ;
Hofman, Albert ;
Ikram, M. Arfan ;
Vernooij, Meike W. .
NEUROLOGY, 2013, 81 (22) :1930-1937
[4]   Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions [J].
Bath, Philip M. ;
Wardlaw, Joanna M. .
INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (04) :469-478
[5]   Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease [J].
Benedictus, Marije R. ;
Goos, Jeroen D. C. ;
Binnewijzend, Maja A. A. ;
Muller, Majon ;
Barkhof, Frederik ;
Scheltens, Philip ;
Prins, Niels D. ;
van der Flier, Wiesje M. .
NEUROBIOLOGY OF AGING, 2013, 34 (11) :2488-2494
[6]  
Bo N, 2008, HDB CLIN NEUROLOGY, V93, P667
[7]   Cerebral Microbleeds Are Not Associated with Long-Term Cognitive Outcome in Patients with Transient Ischemic Attack or Minor Stroke [J].
Brundel, Manon ;
Kwa, Vincent I. H. ;
Bouvy, Willem H. ;
Algra, Ale ;
Kappelle, L. Jaap ;
Biessels, Geert Jan .
CEREBROVASCULAR DISEASES, 2014, 37 (03) :195-202
[8]   Cerebral Microbleeds and Recurrent Stroke Risk Systematic Review and Meta-Analysis of Prospective Ischemic Stroke and Transient Ischemic Attack Cohorts [J].
Charidimou, Andreas ;
Kakar, Puneet ;
Fox, Zoe ;
Werring, David J. .
STROKE, 2013, 44 (04) :995-+
[9]  
Christopher G, 2011, ALZHEIMERS DEMENT, V7, pS698
[10]   Number of Cerebral Microbleeds and Risk of Intracerebral Hemorrhage After Intravenous Thrombolysis [J].
Dannenberg, Steffen ;
Scheitz, Jan F. ;
Rozanski, Michal ;
Erdur, Hebun ;
Brunecker, Peter ;
Werring, David J. ;
Fiebach, Jochen B. ;
Nolte, Christian H. .
STROKE, 2014, 45 (10) :2900-2905